Loading clinical trials...
Loading clinical trials...
Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib (BMS-354825)
Conditions
Interventions
Dasatinib
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
November 8, 2005
Primary Completion Date
March 14, 2025
Completion Date
March 14, 2025
Last Updated
January 15, 2026
NCT02689440
NCT00719888
NCT01428635
NCT00796068
NCT03602898
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions